Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! Please be sure to document all clinical activities daily.
Formulary, restricted to continuation of maintenance regimens (i.e., home med) or initiation of therapy by cardiologists, pulmonologists, rheumatologists and critical care prescribers.
Hospital able to purchase stock of Opsumit from specialty pharmacy (i.e. Accredo or Curascript) for inpatient use.
The Macitentan REMS programs are no longer in effect as of April 2025.
Formulary, restricted to continuation of maintenance regimens (i.e., home med) or initiation of therapy by cardiologists, pulmonologists, rheumatologists and critical care prescribers.
Hospital able to purchase stock of Opsumit from specialty pharmacy (i.e. Accredo or Curascript) for inpatient use.
The Macitentan REMS programs are no longer in effect as of April 2025.
Reviewed: November 18, 2014 (Opsumit)
Updated: June 2020, May 2025 (REMS Update)